Literature DB >> 15381255

PKA-mediated phosphorylation of the beta1-adrenergic receptor promotes Gs/Gi switching.

Negin P Martin1, Erin J Whalen, Musa A Zamah, Kristen L Pierce, Robert J Lefkowitz.   

Abstract

Recently, it has been shown that PKA-mediated phosphorylation of the beta(2)-adrenergic receptor (beta(2)-AR) by the cyclic AMP-dependent protein kinase (PKA) reduces its affinity for G(s) and increases its affinity for G(i). Here we demonstrate that, like the beta(2)-AR, the beta(1)-AR is also capable of "switching" its coupling from G(s) to G(i) in a PKA-dependent manner. The beta(1)-AR is capable of activating adenylate cyclase via G(s), and can also activate the extracellular-regulated kinases, p44 and p42 (ERK1/2). In transfected CHO cells, the observed beta(1)-AR-mediated activation of ERK is both sensitive to pertussis toxin (PTX), indicating involvement of G(i)/G(o), and to the PKA inhibitor, H-89. beta(1)-ARs with PKA phosphorylation sites mutated to alanines are unable to activate ERK. Mutating these same residues to aspartic acid, mimicking PKA phosphorylation, leads to a decrease in G(s)-stimulated cAMP accumulation and an increase in PTX-sensitive ERK activation. These results strongly support the hypothesis that the beta(1)-AR, like the beta(2)-AR, can undergo PKA-dependent "G(s)/G(i) switching".

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15381255     DOI: 10.1016/j.cellsig.2004.05.002

Source DB:  PubMed          Journal:  Cell Signal        ISSN: 0898-6568            Impact factor:   4.315


  47 in total

1.  Disruption of parathyroid hormone and parathyroid hormone-related peptide receptor phosphorylation prolongs ERK1/2 MAPK activation and enhances c-fos expression.

Authors:  Hesham A Tawfeek; Abdul B Abou-Samra
Journal:  Am J Physiol Endocrinol Metab       Date:  2012-03-13       Impact factor: 4.310

2.  Moderate global reduction in maternal nutrition has differential stage of gestation specific effects on {beta}1- and {beta}2-adrenergic receptors in the fetal baboon liver.

Authors:  Amrita Kamat; Mark J Nijland; Thomas J McDonald; Laura A Cox; Peter W Nathanielsz; Cun Li
Journal:  Reprod Sci       Date:  2010-11-15       Impact factor: 3.060

3.  Selectivity in the Use of Gi/o Proteins Is Determined by the DRF Motif in CXCR6 and Is Cell-Type Specific.

Authors:  Satya P Singh; John F Foley; Hongwei H Zhang; Darrell E Hurt; Jennifer L Richards; Craig S Smith; Fang Liao; Joshua M Farber
Journal:  Mol Pharmacol       Date:  2015-08-27       Impact factor: 4.436

4.  Molecular assays for characterization of alternatively spliced isoforms of the u opioid receptor (MOR).

Authors:  Pavel Gris; Philip Cheng; John Pierson; William Maixner; Luda Diatchenko
Journal:  Methods Mol Biol       Date:  2010

5.  Regulation of ERK1/2 activity by ghrelin-activated growth hormone secretagogue receptor 1A involves a PLC/PKCvarepsilon pathway.

Authors:  Delphine Mousseaux; Lionel Le Gallic; Joanne Ryan; Catherine Oiry; Didier Gagne; Jean-Alain Fehrentz; Jean-Claude Galleyrand; Jean Martinez
Journal:  Br J Pharmacol       Date:  2006-06       Impact factor: 8.739

6.  Formyl peptide receptor-mediated ERK1/2 activation occurs through G(i) and is not dependent on beta-arrestin1/2.

Authors:  Jeannie M Gripentrog; Heini M Miettinen
Journal:  Cell Signal       Date:  2007-11-09       Impact factor: 4.315

Review 7.  Processive phosphorylation: mechanism and biological importance.

Authors:  Parag Patwardhan; W Todd Miller
Journal:  Cell Signal       Date:  2007-06-22       Impact factor: 4.315

Review 8.  Viagra for your synapses: Enhancement of hippocampal long-term potentiation by activation of beta-adrenergic receptors.

Authors:  Thomas J O'Dell; Steven A Connor; Jennifer N Gelinas; Peter V Nguyen
Journal:  Cell Signal       Date:  2009-12-31       Impact factor: 4.315

Review 9.  Use of inotropes and vasopressor agents in critically ill patients.

Authors:  Mansoor N Bangash; Ming-Li Kong; Rupert M Pearse
Journal:  Br J Pharmacol       Date:  2012-04       Impact factor: 8.739

10.  Motif-specific sampling of phosphoproteomes.

Authors:  Cristian I Ruse; Daniel B McClatchy; Bingwen Lu; Daniel Cociorva; Akira Motoyama; Sung Kyu Park; John R Yates
Journal:  J Proteome Res       Date:  2008-05       Impact factor: 4.466

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.